Premier Research

BROMANTANE 50MG - 60CT

BROMANTANE 50MG – 60CT

$99.00

BROMANTANE CAPSULES 50MG – 60CT Bromantan is a synthetic adamantane derivative with psychostimulant and actoprotective properties. Preclinical studies in cell cultures and animal models indicate that Bromantan enhances dopaminergic and serotonergic neurotransmission, increases physical endurance, and exhibits adaptogenic effects under extreme conditions without typical stimulant side effects.[1][2] Key Research Areas Physical Performance & Endurance –…

10 in stock

Category: , ,

BROMANTANE CAPSULES 50MG – 60CT

Bromantan is a synthetic adamantane derivative with psychostimulant and actoprotective properties. Preclinical studies in cell cultures and animal models indicate that Bromantan enhances dopaminergic and serotonergic neurotransmission, increases physical endurance, and exhibits adaptogenic effects under extreme conditions without typical stimulant side effects.[1][2]

Key Research Areas

  • Physical Performance & Endurance – In rodent models of exhaustive physical load, Bromantan has been shown to increase work capacity, delay fatigue onset, and improve recovery without increasing oxygen consumption.[3][4]
  • Dopaminergic & Serotonergic Modulation – Preclinical investigations demonstrate Bromantan upregulates dopamine synthesis, enhances serotonergic activity, and improves operant behavior in models of stress and fatigue.[5][6]
  • Adaptogenic & Stress-Protective Effects – Animal studies suggest Bromantan normalizes behavioral and physiological parameters under extreme conditions (e.g., hypoxia, high temperature), supporting its role in adaptation and resilience.[7][8]

Product Specifications

Form Capsules (research use only)
CAS Number 879487-25-2
Molecular Formula C20H30N2Br
Molar Mass 377.36 g/mol
Synonyms Bromantane, Ladasten, 2-(p-bromophenyl)-adamantylamine
Purity ≥99% (HPLC)
Storage Room temp
Other Details Excipients: Research-grade fillers/capsule material

References

  1. 1. Morozov IS, et al. Effect of bromantane on dopaminergic and serotonergic systems. Eksp Klin Farmakol. 1995. PubMed
  2. 2. Vakhitova YV, et al. Effects of ladasten on dopaminergic neurotransmission. Neurochem J. 2007. PubMed
  3. 3. Iasnetsov VV, et al. Toxic effects and psychostimulant properties of bromantane. Bull Exp Biol Med. 2002. PubMed
  4. 4. Iasnetsov VV, et al. Effects of bromantane on physical work capacity. Bull Exp Biol Med. 1999. PubMed
  5. 5. Vakhitova YV, et al. Quantitative pharmaco-EEG analysis of bromantane. Farmakol Toksikol. 1993. (EEG data)
  6. 6. Morozov IS, et al. Effects of bromantane on operant conditioning. Bull Exp Biol Med. 2000. PubMed
  7. 7. Iasnetsov VV, et al. Neuropsychotropic activity of bromantane. Eksp Klin Farmakol. 1999. PubMed
  8. 8. Vakhitova YV, et al. Bromantane as an adaptogen in extreme conditions. Eksp Klin Farmakol. 2005. (Adaptogenic data)
All products offered by Premier Research are intended for laboratory research use only. These materials are not for human or veterinary consumption, medical use, diagnostic procedures, or therapeutic applications. Statements on this website are for informational and educational purposes only and have not been evaluated by the U.S. Food and Drug Administration (FDA). By accessing this site, you confirm that you are a qualified researcher or institution representative and agree to use all materials in accordance with applicable laws, regulations, and safety guidelines.

Related products